Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.

PURPOSE To retrospectively evaluate the effectiveness of radiofrequency (RF) ablation of hepatocellular carcinoma (HCC) by using histologic examination of the explanted liver. MATERIALS AND METHODS The study was approved by the medical center Institutional Review Board, with waiver of informed consent. Forty-seven HCC nodules in 24 patients (18 men, six women; age range, 33-71 years; mean age, 56 years) were treated with single or double RF ablation sessions prior to liver transplantation. Histologic data from hematoxylin-eosin staining of explanted liver specimens were retrospectively reviewed to determine treatment success, which was defined as the absence of residual or recurrent viable carcinoma cells at treatment site. Tumor size and the presence of large (> or =3 mm) abutting vessels that were observed during imaging were tested as potential predictors of treatment success or failure (Fisher exact test). In patients who underwent postablation computed tomographic (CT) or magnetic resonance (MR) imaging within 3 months prior to transplantation (21 patients with 44 tumors), imaging results were analyzed for sensitivity and specificity of residual or recurrent tumor by using histologic data as the reference standard. RESULTS Thirty-five (74%) of 47 ablated tumors, including 29 (83%) of 35 tumors less than 3 cm, were found to be successfully treated on the basis of histologic findings after a mean interval of 7.5 months between RF ablation and transplantation. Nodules that were successfully treated had mean maximal diameter of 2.0 cm, and nodules that were unsuccessfully treated had mean maximal diameter of 3.1 cm (P=.014). Seven (47%) of 15 perivascular lesions were successfully treated whereas 28 (88%) of 32 nonperivascular lesions were successfully treated (P <.01). Imaging correlation showed 100% (33 of 33) specificity and 36% (four of 11) sensitivity of postablation CT and MR imaging for the depiction of residual or recurrent tumor. CONCLUSION Histologic evidence directly validates RF ablation as an effective treatment of small (<3 cm) HCC.

[1]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[2]  Steven A. Curley,et al.  Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis , 2000, Annals of surgery.

[3]  A. Alavi,et al.  FDG Positron Emission Tomography in the Surveillance of Hepatic Tumors Treated with Radiofrequency Ablation , 2003, Clinical nuclear medicine.

[4]  P R Mueller,et al.  Treatment of intrahepatic malignancy with radiofrequency ablation , 2000, Cancer.

[5]  Carlo Bartolozzi,et al.  Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results , 2001 .

[6]  T. Davern,et al.  A follow‐up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  O. Catalano,et al.  Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns , 2001, Abdominal Imaging.

[8]  Toshio Imada,et al.  Treatment of hepatocellular carcinoma with radiofrequency ablation: Radiologic‐histologic correlation during follow‐up periods , 2002, Hepatology.

[9]  H. Hussain,et al.  Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  C. Bartolozzi,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. , 2001, AJR. American journal of roentgenology.

[11]  T. Ishibashi,et al.  Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. , 2001, Clinical imaging.

[12]  W. Lau,et al.  Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma: A Review and Look Into the Future , 2003, Annals of surgery.

[13]  Adrian Fisher,et al.  Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. , 2003, Journal of the American College of Surgeons.

[14]  E. Patterson,et al.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. , 1998, Annals of surgery.

[15]  H. Hussain,et al.  Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. , 2002, Current problems in diagnostic radiology.

[16]  L Solbiati,et al.  Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? , 1998, Journal of vascular and interventional radiology : JVIR.

[17]  S. Goldberg,et al.  Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. , 2001, AJR. American journal of roentgenology.

[18]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[19]  G. Gazelle,et al.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. , 2000, Radiology.

[20]  V. Mazzaferro,et al.  Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. , 2001, Transplantation proceedings.

[21]  Kent-Man Chu,et al.  Hepatic Resection for Hepatocellular Carcinoma An Audit of 343 Patients , 1995, Annals of surgery.

[22]  S. Horita,et al.  Immunohistochemical Detection of Hepatocellular Carcinoma in the Setting of Ongoing Necrosis after Radiofrequency Ablation , 2002, Modern Pathology.

[23]  L. Cavanna,et al.  Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. , 1995, The cancer journal from Scientific American.

[24]  Junji Konishi,et al.  Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. , 2002, Radiology.

[25]  James Sayre,et al.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. , 2002, AJR. American journal of roentgenology.

[26]  P. Petrow,et al.  Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. , 2002, Radiology.

[27]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[28]  T. Arima,et al.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation , 2003, Cancer.

[29]  D. Ota,et al.  Radiofrequency ablation of liver tumors: influence of technique and tumor size. , 2002, Surgery.

[30]  James Sayre,et al.  Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. , 2003, Journal of vascular and interventional radiology : JVIR.

[31]  H. Thomas,et al.  Increase in primary liver cancer in the UK, 1979–94 , 1997, The Lancet.